Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Hyperhomocysteinemia MeSH Descriptor Data 2026


MeSH Heading
Hyperhomocysteinemia
Tree Number(s)
C16.320.565.100.480
C18.452.603.378
C18.452.648.100.480
C18.654.521.500.133.699.418
Unique ID
D020138
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D020138
Scope Note
Condition in which the plasma levels of homocysteine and related metabolites are elevated (>13.9 μmol/l). Hyperhomocysteinemia can be familial or acquired. Development of the acquired hyperhomocysteinemia is mostly associated with vitamins B and/or folate deficiency (e.g., PERNICIOUS ANEMIA, vitamin malabsorption). Familial hyperhomocysteinemia often results in a more severe elevation of total homocysteine and excretion into the urine, resulting in HOMOCYSTINURIA. Hyperhomocysteinemia is a risk factor for cardiovascular and neurodegenerative diseases, osteoporotic fractures and complications during pregnancy.
NLM Classification #
QU 265.5.A5
Previous Indexing
Homocysteine/blood (1991-1998)
Public MeSH Note
1999
History Note
1999
Date Introduced
1999/01/01
Last Updated
2009/07/06
Hyperhomocysteinemia Preferred
page delivered in 0.218s